Dashboard
My Portfolio
Backtest
New
Portfolios
Investors
Analysts
Community
Calendars
Economic Calendar
Dividend Calendar
Earnings Calendar
Splits Calendar
IPO Calendar
Markets
Stocks
Indices
Forex
Crypto
Commodities
News
Sign Up
Sign In
Your search results will appear here.
Light Mode
Dark Mode
Sign Up
Sign In
Kissei Pharmaceutical Co., Ltd. (KSPHF)
Market Closed
13 Oct, 08:00 PM
OTC PINK
All
(2)
JP
(1)
US
(1)
JPX
Primary
OTC PINK
$
24.
50
0
0%
$
1.07B
Market Cap
-
P/E Ratio
1.26%
Div Yield
100
Volume
-
Eps
$
24.5
Previous Close
Watching
Watch
Add Transaction
Day Range
24.5
24.5
Year Range
24.5
31.9
Want to track
KSPHF
and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free
Overview
Dividends
Earnings
Splits
Statistics
Historical Data
Kissei Pharmaceutical Co., Ltd. (KSPHF) Statistics
Valuation metrics
Market Cap
1.07B
Enterprise value
124.87B
Trailing P/E (ttm)
11
Forward P/E
-
PEG ratio
0.67
Price/Sales (ttm)
1.56
Price/Book (mrq)
0.67
Enterprise Value/Revenue
1.27
Enterprise Value/EBITDA
7.35
Overview
Shares outstanding
41.45M
Float
27.96M
Shares short
-
% Held by insiders
0.23%
% Held by institutions
0.23%
Average volume (10 days)
76
Average volume (90 days)
14
Price summary
52-Week low
24.5
52-Week high
31.9
Beta
-0.13
50-Day moving average
19.33
200-Day moving average
24.2
Dividends and splits
Forward annual dividend rate
1.26
Forward annual dividend yield
0.0489%
Trailing annual dividend rate
205
Trailing annual dividend yield
0.0553%
5-Year annual dividend yield
1.64%
Payout ratio
0.34
Dividend Date
30 Sep 2026
Ex-Dividend Date
30 Sep 2026
Last split factor
11:10
Last split Date
26 Mar 1996
Financials
Fiscal year
Fiscal year ends
31 Mar 2025
Most recent quarter (mrq)
30 Jun 2025
Profitability
Profit margin
0.14%
Operating margin
-0.04%
Operational effectiveness
Return on assets
0.05%
Return on equity
0.06%
Income Statement
Revenue (ttm)
598.92M
Revenue per share (ttm)
2,378.75
Quarterly revenue growth (yoy)
0.15%
Gross profit (ttm)
288.73M
EBITDA
11.64B
Net income to common (ttm)
88.84M
Diluted EPS (ttm)
337.31
Quarterly earnings growth (yoy)
-0.1%
Balance Sheet
Total cash (mrq)
293.7M
Total cash per share (mrq)
1,277.48
Total debt (mrq)
7.98M
Total Debt/Equity (mrq)
0.01
Current ratio (mrq)
6.03%
Book value per share (mrq)
5,559.43
Cash Flow
Cash flow statement
13.94B
Levered free cash flow (LFCF)
11.96B